IVERIC Bio Current Valuation vs. Gross Profit

ISEEDelisted Stock  USD 39.95  0.00  0.00%   
Considering IVERIC Bio's profitability and operating efficiency indicators, IVERIC Bio may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess IVERIC Bio's ability to earn profits and add value for shareholders.
For IVERIC Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of IVERIC Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well IVERIC Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between IVERIC Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of IVERIC Bio over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Please note, there is a significant difference between IVERIC Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if IVERIC Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IVERIC Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

IVERIC Bio Gross Profit vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining IVERIC Bio's current stock value. Our valuation model uses many indicators to compare IVERIC Bio value to that of its competitors to determine the firm's financial worth.
IVERIC Bio is rated below average in current valuation category among its peers. It is rated below average in gross profit category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value IVERIC Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

IVERIC Current Valuation vs. Competition

IVERIC Bio is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 70.74 Billion. IVERIC Bio holds roughly 4.98 Billion in current valuation claiming about 7% of equities under Health Care industry.

IVERIC Gross Profit vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

IVERIC Bio

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
4.98 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

IVERIC Bio

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
(117.01 M)
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

IVERIC Gross Profit Comparison

IVERIC Bio is currently under evaluation in gross profit category among its peers.

IVERIC Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in IVERIC Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, IVERIC Bio will eventually generate negative long term returns. The profitability progress is the general direction of IVERIC Bio's change in net profit over the period of time. It can combine multiple indicators of IVERIC Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases . The company was incorporated in 2007 and is based in Parsippany, New Jersey. Iveric Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

IVERIC Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on IVERIC Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of IVERIC Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the IVERIC Bio's important profitability drivers and their relationship over time.

Use IVERIC Bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IVERIC Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IVERIC Bio will appreciate offsetting losses from the drop in the long position's value.

IVERIC Bio Pair Trading

IVERIC Bio Pair Trading Analysis

The ability to find closely correlated positions to IVERIC Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IVERIC Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IVERIC Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling IVERIC Bio to buy it.
The correlation of IVERIC Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IVERIC Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if IVERIC Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IVERIC Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your IVERIC Bio position

In addition to having IVERIC Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run ESG Investing Thematic Idea Now

ESG Investing
ESG Investing Theme
Sustainable investments that promote the conservation of the natural world, social resposibility, freindly employees policies and strong governance. The ESG Investing theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ESG Investing Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Consideration for investing in IVERIC Stock

If you are still planning to invest in IVERIC Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IVERIC Bio's history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.